KR vs CVS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
KR · The Kroger Co.$68.44 ▲ 0.74%
CVS · CVS Health$80.84 ▲ 1.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- KR +8.9%
- CVS +6.2%
Head to head
| Metric | KR | CVS |
|---|---|---|
| Price | $68.44 | $80.84 |
| Change today | ▲ 0.74% | ▲ 1.00% |
| Market cap | $40.79B | $103.43B |
| Return, 3 months | +16.5% | -14.1% |
| Return, year to date | +12.0% | +4.2% |
| Return, 1 year | +6.0% | +6.0% |
| P/E (TTM) | 37.0 | 9.4 |
| P/B | 6.9 | 1.3 |
| P/E percentile vs own 5y | 89th | 7th |
| Dividend yield | 2.05% | 3.29% |
| Revenue growth (YoY, latest qtr) | +2.0% | +5.4% |
| Net profit growth (YoY) | +5.2% | +154.4% |
| Gross margin | 23.1% | 14.2% |
| Operating margin | 1.4% | 3.6% |
| Net margin | 0.7% | 2.6% |
| Return on equity | 14.2% | 14.4% |
| Analyst target vs. price | +3.8% | +36.6% |
| Analyst buy share | 69% | 100% |
| RSI (14) | 56 | 37 |
| 30-day volatility | 31.3% | 51.7% |
| Max drawdown, 1 year | -26.2% | -27.3% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CVS is the largest of the group by market value.
- CVS has returned the most over the past year.
- CVS carries the lowest trailing P/E.
- CVS pays the highest dividend yield.
- CVS is growing revenue fastest.
- CVS keeps the most profit per dollar of sales.
- KR has been the calmest stock over the last 30 days.